| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/13/2003 | US20030032118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032117 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032116 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032115 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032114 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032112 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032111 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032110 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032109 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032108 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032107 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032106 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032105 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders |
| 02/13/2003 | US20030032104 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032103 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032102 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032101 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032096 Parathyroid hormone receptor ligands |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | US20030032094 Isolated mammalian dendritic cell genes; related reagents |
| 02/13/2003 | US20030032090 Human receptor proteins; related reagents and methods |
| 02/13/2003 | US20030032089 Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein |
| 02/13/2003 | US20030032088 Non-oligomerizing tandem fluorescent proteins |
| 02/13/2003 | US20030032087 121P1F1: a tissue specific protein highly expressed in various cancers |
| 02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |
| 02/13/2003 | US20030032083 Biosynthesis of preferential peptide; obtain amino acid sequence, ligate protection group, deprotect peptide, recover peptide |
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032061 Nucleotide sequences coding polypeptide for use in the treatment of inflammation, tumors and immunological and inflammatory bowel disease |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032058 Protein-protein interactions |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032050 Methods and compositions using peptide-pulsed dendritic cells for stimulating cytotoxic T lymphocytes specific for tumor cells or virus-infected cells |
| 02/13/2003 | US20030032038 AMPA-binding human GluR3 receptors |
| 02/13/2003 | US20030032034 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 02/13/2003 | US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection |
| 02/13/2003 | US20030032031 Diagnosing liver defects in humans; obtain fluid sample, determine concentration of viral core protein present, evaluate for liver defects |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030032021 44589, a novel human ABC transporter family member and uses thereof |
| 02/13/2003 | US20030032019 Novel G protein-coupled receptors |
| 02/13/2003 | US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
| 02/13/2003 | US20030032010 Methods of populating data structures for use in evolutionary simulations |
| 02/13/2003 | US20030032009 09007761method for influencing the p53 linkage to target genes |
| 02/13/2003 | US20030032006 A PC12 cell quiescently infected with a human herpes simplex 2 virus (HSV-2); determining the ability of a test reagent to suppress virus reactivation from a quiescently-infected PC12 cells |
| 02/13/2003 | US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 02/13/2003 | US20030031716 Biocompatible polymer and particles of metal cation-stabilized interferon dispersed within the polymer |
| 02/13/2003 | US20030031686 Exposing a source animal to an antigenic agent to elicit a T-cell mediated immune response, collecting an egg from the source that transfers cellular immunity to another animal in vivo |
| 02/13/2003 | US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis |
| 02/13/2003 | US20030031680 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031678 Compositions and methods relating to prostate specific genes and proteins |
| 02/13/2003 | US20030031675 For the immunomodulation of a human or animal; decreasing T-cell proliferation |
| 02/13/2003 | US20030031670 Diagnosis and treatment of malignant neoplasms |
| 02/13/2003 | US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 02/13/2003 | US20030031667 Human monoclonal antibodies to dendritic cells |
| 02/13/2003 | US20030031666 Antibodies that bind IL-13 mutants |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031662 Delivering pituitary tumor transforming gene carboxy-terminal peptide (PTTG-C) to mammalian cell such that the PTTG-C peptide is expressed in the cell, whereby neoplastic cellular proliferation and/or transformation of the cell is inhibited |
| 02/13/2003 | US20030031661 Methods of recovering chaperone proteins and complexes thereof |
| 02/13/2003 | US20030031654 Prohormone convertase transformed cells and polypeptide synthesis |
| 02/13/2003 | US20030031646 Mammalian chemokines; related reagents |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | CA2494304A1 Materials and methods relating to improved vaccination strategies |
| 02/13/2003 | CA2456821A1 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 02/13/2003 | CA2456199A1 Gene associated with bone disorders |
| 02/13/2003 | CA2456196A1 Compositions and methods for modulation of immune responses |
| 02/13/2003 | CA2456007A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
| 02/13/2003 | CA2456003A1 Regulator of calcineurin |
| 02/13/2003 | CA2455963A1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/13/2003 | CA2455462A1 Androgen receptor knock-out transgenic animals |
| 02/13/2003 | CA2455398A1 Use of peptide fragments of the calcium channel .alpha.-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest |
| 02/13/2003 | CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455154A1 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | CA2455038A1 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454899A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 02/13/2003 | CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 02/13/2003 | CA2454696A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production |
| 02/13/2003 | CA2454421A1 Use of long pentraxin ptx3 for treating female infertility |
| 02/13/2003 | CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453840A1 Isp-1 and ctb-1 genes and uses thereof |
| 02/13/2003 | CA2453833A1 Tnf receptor 2 related protein variant |
| 02/13/2003 | CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2439219A1 Plant stress regulated genes |
| 02/12/2003 | EP1283272A2 Methods and means for assessing HIV envelope inhibitor therapy |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283267A1 Vector for analysing replication mechanism of rna virus and use thereof |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283263A1 Modified cDNA for high expression levels of factor VIII and its derivatives |
| 02/12/2003 | EP1283262A1 Neurotrophic factor expression-inducing agent |